2015
DOI: 10.1016/j.cnre.2015.03.001
|View full text |Cite
|
Sign up to set email alerts
|

Subglottic secretion drainage for preventing ventilator associated pneumonia: A meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
15
0
3

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 25 publications
0
15
0
3
Order By: Relevance
“…When only including studies that enrolled subjects expected to require (Table 2). [139][140][141][142] Regardless of the combination of the studies included in the analysis, the results suggest that SSD results in a reduction of VAP by ϳ50% and may be associated with reduced early onset of VAP, shorter duration of mechanical ventilation, and fewer days in the ICU, but not a reduced mortality.…”
Section: Subglottic Secretion Drainagementioning
confidence: 91%
See 1 more Smart Citation
“…When only including studies that enrolled subjects expected to require (Table 2). [139][140][141][142] Regardless of the combination of the studies included in the analysis, the results suggest that SSD results in a reduction of VAP by ϳ50% and may be associated with reduced early onset of VAP, shorter duration of mechanical ventilation, and fewer days in the ICU, but not a reduced mortality.…”
Section: Subglottic Secretion Drainagementioning
confidence: 91%
“…Another study using continuous aspiration of subglottic secretions reported a 40% incidence of postextubation laryngeal edema and considered it an adverse outcome of SSD. 133 These issues have not been reported using intermittent SSD, and given that the intermittent method appears to affect VAP similarly as continuous aspiration, 140 intermittent SSD may be preferred.…”
Section: Subglottic Secretion Drainagementioning
confidence: 99%
“…On the other hand, Bo et al [34], Wang et al [35] and Dezfulian et al [36], published papers show that there is no statistical significant in late onset VAP. Wang et al reveals that SSD significantly reduced early onset VAP (RR=0.23, 95% CI:0.13-0.43, p<0.00001), while late onset of VAP (RR=1.15, 95% CI: 0.51-2.61, p<0.73) [35], Dezfulian suggests that SSD is ineffective in preventing late onset VAP because P. aeruginosa and other Gram negative bacilli, can colonize the trachea without first appearing in the oropharyngeal or subglottic secretions, possibly through adhesion to endotracheal tube biofilm, that indicate that microaspiration may be less relevant to the pathogenesis of pneumonia with these organisms [36]. On the other hand Bo et al [34] proves that there is a decrease in the incidence of VAP with SSD (P<0.05) and indicates that the efficacy is due to significant reduction caused by Gram-positive cocci and Haemophilus influenzae organisms.…”
Section: Subglottic Secretion Drainage (Ssd)mentioning
confidence: 99%
“…The effect of SSD is further than decreasing the VAP incidence; there is a significant shorten of the mechanical ventilation (by 1.55 days), and delayed the onset of VAP [35], stay in the ICU (about 3 days) for patient with SSD [36,38], Those effects are reflected on the cost as well, despite the use of SSD tube costs $14 more than usual ETT, SSD saves around $4,000 saved per case [39].…”
Section: Subglottic Secretion Drainage (Ssd)mentioning
confidence: 99%
See 1 more Smart Citation